Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01350
|
|||||
Drug Name |
Flesinoxan
|
|||||
Synonyms |
Flesinoxan hydrochloride; DU-29373
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Anxiety disorder [ICD11: 6B00] | Discontinued in Phase 3 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C22H26FN3O4
|
|||||
Canonical SMILES |
C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=C4C(=CC=C3)OC(CO4)CO
|
|||||
InChI |
InChI=1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)/t18-/m0/s1
|
|||||
InChIKey |
NYSDRDDQELAVKP-SFHVURJKSA-N
|
|||||
CAS Number |
CAS 98206-10-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 415.5 | Topological Polar Surface Area | 74.3 | ||
Heavy Atom Count | 30 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
2
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001126) | |||||
2 | Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. Eur J Pharm Sci. 2001 Aug;14(1):81-6. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.